Profile
Sector:
HealthcareIndustry:
BiotechnologyCountry:
United StatesIPO:
15 June 2021Website:
http://www.alzamend.comNext earnings report:
13 December 2024Last dividends:
N/ANext dividends:
N/APrice
regular market | 13 min agoDividend
Analysts recommendations
Institutional Ownership
ALZN Latest News
Developing groundbreaking drugs and devices entails high costs, uncertain regulatory approval, and lucrative revenues. Those factors and more culminate to create a sector filled with dozens of biotech stocks that have 10X potential, or better.
Turning $1,000 into $10,000 in a year in the stock market is undoubtedly a lofty goal. Make no bones about it, it's not particularly likely to happen.
What type of business is Alzamend Neuro?
Alzamend Neuro, Inc., a clinical-stage biopharmaceutical company, focuses on developing various products for the treatment of neurodegenerative and psychiatric disorders. Its pipeline includes AL001, which delivers a therapeutic combination of lithium, proline, and salicylate for the treatment of Alzheimer's, bi-polar disorder, post-traumatic stress disorder, major depressive disorder, other neurodegenerative diseases, and psychiatric disorders; and ALZN002 stage, which uses a method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine to restore the ability of a patient's immunological system to combat Alzheimer's disease. The company has partnership agreement with Massachusetts General Hospital for the Phase II clinical trial of AL001. Alzamend Neuro, Inc. was incorporated in 2016 and is headquartered in Atlanta, Georgia.
What sector is Alzamend Neuro in?
Alzamend Neuro is in the Healthcare sector
What industry is Alzamend Neuro in?
Alzamend Neuro is in the Biotechnology industry
What country is Alzamend Neuro from?
Alzamend Neuro is headquartered in United States
When did Alzamend Neuro go public?
Alzamend Neuro initial public offering (IPO) was on 15 June 2021
What is Alzamend Neuro website?
https://www.alzamend.com
Is Alzamend Neuro in the S&P 500?
No, Alzamend Neuro is not included in the S&P 500 index
Is Alzamend Neuro in the NASDAQ 100?
No, Alzamend Neuro is not included in the NASDAQ 100 index
Is Alzamend Neuro in the Dow Jones?
No, Alzamend Neuro is not included in the Dow Jones index
When was Alzamend Neuro the previous earnings report?
No data
When does Alzamend Neuro earnings report?
The next expected earnings date for Alzamend Neuro is 13 December 2024